Gonadal function in women treated with cyclophosphamide for childhood nephrotic syndrome: a long-term follow-up study.
The gonadal function of 18 women who were treated for childhood nephrotic syndrome at a mean age of 10.7 years with cyclophosphamide (mean dosage, 28 gm; mean duration of therapy, 354 days) was evaluated at a mean of 14.5 years after treatment by means of detailed questionnaires. Menstrual patterns were normal in all except two, who were still receiving intermittent prednisone therapy. Eight healthy children had been born to five mothers. Compared with males, there is little current evidence of gonadal toxicity in this patient group. Further follow-up is required to determine whether these women will undergo premature menopause.
D000293:Adolescent; D000328:Adult; D002648:Child; D003520:Cyclophosphamide / Q000009:adverse effects* / Q000627:therapeutic use; D005260:Female; D005500:Follow-Up Studies; D005836:Genitalia, Female / Q000187:drug effects*; D006801:Humans; D008297:Male; D008598:Menstruation / Q000187:drug effects; D008599:Menstruation Disturbances / Q000139:chemically induced; D009404:Nephrotic Syndrome / Q000188:drug therapy*; D011247:Pregnancy / Q000187:drug effects; D012737:Sex Factors
D003520:Cyclophosphamide